Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FSN vs Celecoxib for Senile Knee Osteoarthritis
NCT06328153Not yet recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Mar 2024
- Primary completion
- Jan 2026
01
Overview
Randomised, open-label trial (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Visual Analogue Scale at 14 days. Planned start Mar 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06328153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06328153.